Apr 28, 2020
Denovo Biopharma To Acquire Tocagen's Entire Replicating Gene Therapy Platform and Related Assets
Nov 12, 2019
Tocagen Reports Third Quarter 2019 Financial Results and Business Updates
Nov 08, 2019
Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting
Oct 03, 2019
Tocagen Announces Restructuring to Focus on Clinical Development
Aug 08, 2019
Tocagen Reports Second Quarter 2019 Financial Results and Business Updates
May 30, 2019
Tocagen to Present at Upcoming Jefferies 2019 Healthcare Conference
May 21, 2019
Tocagen's Toca 5 Pivotal Phase 3 Clinical Trial in Patients with Recurrent Brain Cancer Continues Without Modification at Planned Interim Analysis
Apr 30, 2019
Tocagen to Report First Quarter 2019 Financial and Business Results on Tuesday, May 7
Apr 15, 2019
Tocagen Appoints Fairooz Kabbinavar, M.D., FACP, as Senior Vice President, Clinical Development
Mar 27, 2019
Tocagen to Present Updated Data from Clinical and Preclinical Studies at Two Scientific Conferences
Feb 27, 2019
Tocagen Reports Fourth Quarter and Full Year 2018 Financial and Business Results
Dec 12, 2018
Tocagen Announces Pricing of Public Offering of Common Stock
Dec 11, 2018
Tocagen Announces Proposed Public Offering of Common Stock
Nov 29, 2018
Tocagen and NRG Oncology to Collaborate on a Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma
Nov 15, 2018
Tocagen Appoints Lori Kunkel, M.D. as Acting Chief Medical Officer
Nov 08, 2018
Tocagen Reports Third Quarter 2018 Financial and Business Results
Nov 07, 2018
Tocagen to Participate in Investor Conferences in November
Nov 06, 2018
Tocagen to Present Updated Data from Clinical and Preclinical Studies at Three Scientific and Medical Conferences
Nov 01, 2018
Tocagen to Report Third Quarter 2018 Financial Results on Thursday, November 8
Oct 02, 2018
Tocagen Provides Update on European Regulatory Path for Toca 511 & Toca FC